Global GPCR-targeting Drug Supply, Demand and Key Producers, 2023-2029
The global GPCR-targeting Drug market size is expected to reach $ 491.3 million by 2029, rising at a market growth of 2.5% CAGR during the forecast period (2023-2029).
GPCRs or G protein-coupled receptors are proteins located on the cell surface that recognize extracellular substances and transmit signals across the cell membrane. GPCRs do this by activating guanine nucleotide-binding proteins (G protein) that are responsible for signal transduction inside the cell. The signal delivery is very important in various cellular responses including cell growth, gene transcription, post-translational changes, and communication with other cells. This brings on adjustments in the body to adapt to the environmental changes such as increased heart rate when feeling threatened or change in vision in response to dim light.
This report studies the global GPCR-targeting Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for GPCR-targeting Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GPCR-targeting Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GPCR-targeting Drug total market, 2018-2029, (USD Million)
Global GPCR-targeting Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: GPCR-targeting Drug total market, key domestic companies and share, (USD Million)
Global GPCR-targeting Drug revenue by player and market share 2018-2023, (USD Million)
Global GPCR-targeting Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global GPCR-targeting Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global GPCR-targeting Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PerkinElmer, Thermo Fisher Scientific, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam and Corning, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GPCR-targeting Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global GPCR-targeting Drug Market, By Region:
1. How big is the global GPCR-targeting Drug market?
2. What is the demand of the global GPCR-targeting Drug market?
3. What is the year over year growth of the global GPCR-targeting Drug market?
4. What is the total value of the global GPCR-targeting Drug market?
5. Who are the major players in the global GPCR-targeting Drug market?
6. What are the growth factors driving the market demand?
GPCRs or G protein-coupled receptors are proteins located on the cell surface that recognize extracellular substances and transmit signals across the cell membrane. GPCRs do this by activating guanine nucleotide-binding proteins (G protein) that are responsible for signal transduction inside the cell. The signal delivery is very important in various cellular responses including cell growth, gene transcription, post-translational changes, and communication with other cells. This brings on adjustments in the body to adapt to the environmental changes such as increased heart rate when feeling threatened or change in vision in response to dim light.
This report studies the global GPCR-targeting Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for GPCR-targeting Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GPCR-targeting Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GPCR-targeting Drug total market, 2018-2029, (USD Million)
Global GPCR-targeting Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: GPCR-targeting Drug total market, key domestic companies and share, (USD Million)
Global GPCR-targeting Drug revenue by player and market share 2018-2023, (USD Million)
Global GPCR-targeting Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global GPCR-targeting Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global GPCR-targeting Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PerkinElmer, Thermo Fisher Scientific, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam and Corning, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GPCR-targeting Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global GPCR-targeting Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Reagent Test Kit
- Substrate
- Oncology
- Cardiovascular
- Central Nervous
- Other
- PerkinElmer
- Thermo Fisher Scientific
- Merck
- BD Biosciences
- Molecular Devices
- Promega
- Qiagen
- Abcam
- Corning
- Discoverx
- Cisbio
1. How big is the global GPCR-targeting Drug market?
2. What is the demand of the global GPCR-targeting Drug market?
3. What is the year over year growth of the global GPCR-targeting Drug market?
4. What is the total value of the global GPCR-targeting Drug market?
5. Who are the major players in the global GPCR-targeting Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 GPCR-targeting Drug Introduction
1.2 World GPCR-targeting Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World GPCR-targeting Drug Total Market by Region (by Headquarter Location)
1.3.1 World GPCR-targeting Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States GPCR-targeting Drug Market Size (2018-2029)
1.3.3 China GPCR-targeting Drug Market Size (2018-2029)
1.3.4 Europe GPCR-targeting Drug Market Size (2018-2029)
1.3.5 Japan GPCR-targeting Drug Market Size (2018-2029)
1.3.6 South Korea GPCR-targeting Drug Market Size (2018-2029)
1.3.7 ASEAN GPCR-targeting Drug Market Size (2018-2029)
1.3.8 India GPCR-targeting Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 GPCR-targeting Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GPCR-targeting Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World GPCR-targeting Drug Consumption Value (2018-2029)
2.2 World GPCR-targeting Drug Consumption Value by Region
2.2.1 World GPCR-targeting Drug Consumption Value by Region (2018-2023)
2.2.2 World GPCR-targeting Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States GPCR-targeting Drug Consumption Value (2018-2029)
2.4 China GPCR-targeting Drug Consumption Value (2018-2029)
2.5 Europe GPCR-targeting Drug Consumption Value (2018-2029)
2.6 Japan GPCR-targeting Drug Consumption Value (2018-2029)
2.7 South Korea GPCR-targeting Drug Consumption Value (2018-2029)
2.8 ASEAN GPCR-targeting Drug Consumption Value (2018-2029)
2.9 India GPCR-targeting Drug Consumption Value (2018-2029)
3 WORLD GPCR-TARGETING DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World GPCR-targeting Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global GPCR-targeting Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for GPCR-targeting Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for GPCR-targeting Drug in 2022
3.3 GPCR-targeting Drug Company Evaluation Quadrant
3.4 GPCR-targeting Drug Market: Overall Company Footprint Analysis
3.4.1 GPCR-targeting Drug Market: Region Footprint
3.4.2 GPCR-targeting Drug Market: Company Product Type Footprint
3.4.3 GPCR-targeting Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: GPCR-targeting Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: GPCR-targeting Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: GPCR-targeting Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: GPCR-targeting Drug Consumption Value Comparison
4.2.1 United States VS China: GPCR-targeting Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: GPCR-targeting Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based GPCR-targeting Drug Companies and Market Share, 2018-2023
4.3.1 United States Based GPCR-targeting Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies GPCR-targeting Drug Revenue, (2018-2023)
4.4 China Based Companies GPCR-targeting Drug Revenue and Market Share, 2018-2023
4.4.1 China Based GPCR-targeting Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies GPCR-targeting Drug Revenue, (2018-2023)
4.5 Rest of World Based GPCR-targeting Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based GPCR-targeting Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies GPCR-targeting Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World GPCR-targeting Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Reagent Test Kit
5.2.2 Substrate
5.3 Market Segment by Type
5.3.1 World GPCR-targeting Drug Market Size by Type (2018-2023)
5.3.2 World GPCR-targeting Drug Market Size by Type (2024-2029)
5.3.3 World GPCR-targeting Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World GPCR-targeting Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Cardiovascular
6.2.3 Central Nervous
6.2.4 Other
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World GPCR-targeting Drug Market Size by Application (2018-2023)
6.3.2 World GPCR-targeting Drug Market Size by Application (2024-2029)
6.3.3 World GPCR-targeting Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 PerkinElmer
7.1.1 PerkinElmer Details
7.1.2 PerkinElmer Major Business
7.1.3 PerkinElmer GPCR-targeting Drug Product and Services
7.1.4 PerkinElmer GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 PerkinElmer Recent Developments/Updates
7.1.6 PerkinElmer Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Details
7.2.2 Thermo Fisher Scientific Major Business
7.2.3 Thermo Fisher Scientific GPCR-targeting Drug Product and Services
7.2.4 Thermo Fisher Scientific GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.3 Merck
7.3.1 Merck Details
7.3.2 Merck Major Business
7.3.3 Merck GPCR-targeting Drug Product and Services
7.3.4 Merck GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Merck Recent Developments/Updates
7.3.6 Merck Competitive Strengths & Weaknesses
7.4 BD Biosciences
7.4.1 BD Biosciences Details
7.4.2 BD Biosciences Major Business
7.4.3 BD Biosciences GPCR-targeting Drug Product and Services
7.4.4 BD Biosciences GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 BD Biosciences Recent Developments/Updates
7.4.6 BD Biosciences Competitive Strengths & Weaknesses
7.5 Molecular Devices
7.5.1 Molecular Devices Details
7.5.2 Molecular Devices Major Business
7.5.3 Molecular Devices GPCR-targeting Drug Product and Services
7.5.4 Molecular Devices GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Molecular Devices Recent Developments/Updates
7.5.6 Molecular Devices Competitive Strengths & Weaknesses
7.6 Promega
7.6.1 Promega Details
7.6.2 Promega Major Business
7.6.3 Promega GPCR-targeting Drug Product and Services
7.6.4 Promega GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Promega Recent Developments/Updates
7.6.6 Promega Competitive Strengths & Weaknesses
7.7 Qiagen
7.7.1 Qiagen Details
7.7.2 Qiagen Major Business
7.7.3 Qiagen GPCR-targeting Drug Product and Services
7.7.4 Qiagen GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Qiagen Recent Developments/Updates
7.7.6 Qiagen Competitive Strengths & Weaknesses
7.8 Abcam
7.8.1 Abcam Details
7.8.2 Abcam Major Business
7.8.3 Abcam GPCR-targeting Drug Product and Services
7.8.4 Abcam GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Abcam Recent Developments/Updates
7.8.6 Abcam Competitive Strengths & Weaknesses
7.9 Corning
7.9.1 Corning Details
7.9.2 Corning Major Business
7.9.3 Corning GPCR-targeting Drug Product and Services
7.9.4 Corning GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Corning Recent Developments/Updates
7.9.6 Corning Competitive Strengths & Weaknesses
7.10 Discoverx
7.10.1 Discoverx Details
7.10.2 Discoverx Major Business
7.10.3 Discoverx GPCR-targeting Drug Product and Services
7.10.4 Discoverx GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Discoverx Recent Developments/Updates
7.10.6 Discoverx Competitive Strengths & Weaknesses
7.11 Cisbio
7.11.1 Cisbio Details
7.11.2 Cisbio Major Business
7.11.3 Cisbio GPCR-targeting Drug Product and Services
7.11.4 Cisbio GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Cisbio Recent Developments/Updates
7.11.6 Cisbio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 GPCR-targeting Drug Industry Chain
8.2 GPCR-targeting Drug Upstream Analysis
8.3 GPCR-targeting Drug Midstream Analysis
8.4 GPCR-targeting Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 GPCR-targeting Drug Introduction
1.2 World GPCR-targeting Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World GPCR-targeting Drug Total Market by Region (by Headquarter Location)
1.3.1 World GPCR-targeting Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States GPCR-targeting Drug Market Size (2018-2029)
1.3.3 China GPCR-targeting Drug Market Size (2018-2029)
1.3.4 Europe GPCR-targeting Drug Market Size (2018-2029)
1.3.5 Japan GPCR-targeting Drug Market Size (2018-2029)
1.3.6 South Korea GPCR-targeting Drug Market Size (2018-2029)
1.3.7 ASEAN GPCR-targeting Drug Market Size (2018-2029)
1.3.8 India GPCR-targeting Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 GPCR-targeting Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GPCR-targeting Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World GPCR-targeting Drug Consumption Value (2018-2029)
2.2 World GPCR-targeting Drug Consumption Value by Region
2.2.1 World GPCR-targeting Drug Consumption Value by Region (2018-2023)
2.2.2 World GPCR-targeting Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States GPCR-targeting Drug Consumption Value (2018-2029)
2.4 China GPCR-targeting Drug Consumption Value (2018-2029)
2.5 Europe GPCR-targeting Drug Consumption Value (2018-2029)
2.6 Japan GPCR-targeting Drug Consumption Value (2018-2029)
2.7 South Korea GPCR-targeting Drug Consumption Value (2018-2029)
2.8 ASEAN GPCR-targeting Drug Consumption Value (2018-2029)
2.9 India GPCR-targeting Drug Consumption Value (2018-2029)
3 WORLD GPCR-TARGETING DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World GPCR-targeting Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global GPCR-targeting Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for GPCR-targeting Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for GPCR-targeting Drug in 2022
3.3 GPCR-targeting Drug Company Evaluation Quadrant
3.4 GPCR-targeting Drug Market: Overall Company Footprint Analysis
3.4.1 GPCR-targeting Drug Market: Region Footprint
3.4.2 GPCR-targeting Drug Market: Company Product Type Footprint
3.4.3 GPCR-targeting Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: GPCR-targeting Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: GPCR-targeting Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: GPCR-targeting Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: GPCR-targeting Drug Consumption Value Comparison
4.2.1 United States VS China: GPCR-targeting Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: GPCR-targeting Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based GPCR-targeting Drug Companies and Market Share, 2018-2023
4.3.1 United States Based GPCR-targeting Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies GPCR-targeting Drug Revenue, (2018-2023)
4.4 China Based Companies GPCR-targeting Drug Revenue and Market Share, 2018-2023
4.4.1 China Based GPCR-targeting Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies GPCR-targeting Drug Revenue, (2018-2023)
4.5 Rest of World Based GPCR-targeting Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based GPCR-targeting Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies GPCR-targeting Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World GPCR-targeting Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Reagent Test Kit
5.2.2 Substrate
5.3 Market Segment by Type
5.3.1 World GPCR-targeting Drug Market Size by Type (2018-2023)
5.3.2 World GPCR-targeting Drug Market Size by Type (2024-2029)
5.3.3 World GPCR-targeting Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World GPCR-targeting Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Cardiovascular
6.2.3 Central Nervous
6.2.4 Other
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World GPCR-targeting Drug Market Size by Application (2018-2023)
6.3.2 World GPCR-targeting Drug Market Size by Application (2024-2029)
6.3.3 World GPCR-targeting Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 PerkinElmer
7.1.1 PerkinElmer Details
7.1.2 PerkinElmer Major Business
7.1.3 PerkinElmer GPCR-targeting Drug Product and Services
7.1.4 PerkinElmer GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 PerkinElmer Recent Developments/Updates
7.1.6 PerkinElmer Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Details
7.2.2 Thermo Fisher Scientific Major Business
7.2.3 Thermo Fisher Scientific GPCR-targeting Drug Product and Services
7.2.4 Thermo Fisher Scientific GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.3 Merck
7.3.1 Merck Details
7.3.2 Merck Major Business
7.3.3 Merck GPCR-targeting Drug Product and Services
7.3.4 Merck GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Merck Recent Developments/Updates
7.3.6 Merck Competitive Strengths & Weaknesses
7.4 BD Biosciences
7.4.1 BD Biosciences Details
7.4.2 BD Biosciences Major Business
7.4.3 BD Biosciences GPCR-targeting Drug Product and Services
7.4.4 BD Biosciences GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 BD Biosciences Recent Developments/Updates
7.4.6 BD Biosciences Competitive Strengths & Weaknesses
7.5 Molecular Devices
7.5.1 Molecular Devices Details
7.5.2 Molecular Devices Major Business
7.5.3 Molecular Devices GPCR-targeting Drug Product and Services
7.5.4 Molecular Devices GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Molecular Devices Recent Developments/Updates
7.5.6 Molecular Devices Competitive Strengths & Weaknesses
7.6 Promega
7.6.1 Promega Details
7.6.2 Promega Major Business
7.6.3 Promega GPCR-targeting Drug Product and Services
7.6.4 Promega GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Promega Recent Developments/Updates
7.6.6 Promega Competitive Strengths & Weaknesses
7.7 Qiagen
7.7.1 Qiagen Details
7.7.2 Qiagen Major Business
7.7.3 Qiagen GPCR-targeting Drug Product and Services
7.7.4 Qiagen GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Qiagen Recent Developments/Updates
7.7.6 Qiagen Competitive Strengths & Weaknesses
7.8 Abcam
7.8.1 Abcam Details
7.8.2 Abcam Major Business
7.8.3 Abcam GPCR-targeting Drug Product and Services
7.8.4 Abcam GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Abcam Recent Developments/Updates
7.8.6 Abcam Competitive Strengths & Weaknesses
7.9 Corning
7.9.1 Corning Details
7.9.2 Corning Major Business
7.9.3 Corning GPCR-targeting Drug Product and Services
7.9.4 Corning GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Corning Recent Developments/Updates
7.9.6 Corning Competitive Strengths & Weaknesses
7.10 Discoverx
7.10.1 Discoverx Details
7.10.2 Discoverx Major Business
7.10.3 Discoverx GPCR-targeting Drug Product and Services
7.10.4 Discoverx GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Discoverx Recent Developments/Updates
7.10.6 Discoverx Competitive Strengths & Weaknesses
7.11 Cisbio
7.11.1 Cisbio Details
7.11.2 Cisbio Major Business
7.11.3 Cisbio GPCR-targeting Drug Product and Services
7.11.4 Cisbio GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Cisbio Recent Developments/Updates
7.11.6 Cisbio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 GPCR-targeting Drug Industry Chain
8.2 GPCR-targeting Drug Upstream Analysis
8.3 GPCR-targeting Drug Midstream Analysis
8.4 GPCR-targeting Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World GPCR-targeting Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World GPCR-targeting Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World GPCR-targeting Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World GPCR-targeting Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World GPCR-targeting Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World GPCR-targeting Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World GPCR-targeting Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World GPCR-targeting Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World GPCR-targeting Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key GPCR-targeting Drug Players in 2022
Table 12. World GPCR-targeting Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global GPCR-targeting Drug Company Evaluation Quadrant
Table 14. Head Office of Key GPCR-targeting Drug Player
Table 15. GPCR-targeting Drug Market: Company Product Type Footprint
Table 16. GPCR-targeting Drug Market: Company Product Application Footprint
Table 17. GPCR-targeting Drug Mergers & Acquisitions Activity
Table 18. United States VS China GPCR-targeting Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China GPCR-targeting Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based GPCR-targeting Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies GPCR-targeting Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies GPCR-targeting Drug Revenue Market Share (2018-2023)
Table 23. China Based GPCR-targeting Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies GPCR-targeting Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies GPCR-targeting Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based GPCR-targeting Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies GPCR-targeting Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies GPCR-targeting Drug Revenue Market Share (2018-2023)
Table 29. World GPCR-targeting Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World GPCR-targeting Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World GPCR-targeting Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World GPCR-targeting Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World GPCR-targeting Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World GPCR-targeting Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. PerkinElmer Basic Information, Area Served and Competitors
Table 36. PerkinElmer Major Business
Table 37. PerkinElmer GPCR-targeting Drug Product and Services
Table 38. PerkinElmer GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. PerkinElmer Recent Developments/Updates
Table 40. PerkinElmer Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific GPCR-targeting Drug Product and Services
Table 44. Thermo Fisher Scientific GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Merck Basic Information, Area Served and Competitors
Table 48. Merck Major Business
Table 49. Merck GPCR-targeting Drug Product and Services
Table 50. Merck GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Merck Recent Developments/Updates
Table 52. Merck Competitive Strengths & Weaknesses
Table 53. BD Biosciences Basic Information, Area Served and Competitors
Table 54. BD Biosciences Major Business
Table 55. BD Biosciences GPCR-targeting Drug Product and Services
Table 56. BD Biosciences GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. BD Biosciences Recent Developments/Updates
Table 58. BD Biosciences Competitive Strengths & Weaknesses
Table 59. Molecular Devices Basic Information, Area Served and Competitors
Table 60. Molecular Devices Major Business
Table 61. Molecular Devices GPCR-targeting Drug Product and Services
Table 62. Molecular Devices GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Molecular Devices Recent Developments/Updates
Table 64. Molecular Devices Competitive Strengths & Weaknesses
Table 65. Promega Basic Information, Area Served and Competitors
Table 66. Promega Major Business
Table 67. Promega GPCR-targeting Drug Product and Services
Table 68. Promega GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Promega Recent Developments/Updates
Table 70. Promega Competitive Strengths & Weaknesses
Table 71. Qiagen Basic Information, Area Served and Competitors
Table 72. Qiagen Major Business
Table 73. Qiagen GPCR-targeting Drug Product and Services
Table 74. Qiagen GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Qiagen Recent Developments/Updates
Table 76. Qiagen Competitive Strengths & Weaknesses
Table 77. Abcam Basic Information, Area Served and Competitors
Table 78. Abcam Major Business
Table 79. Abcam GPCR-targeting Drug Product and Services
Table 80. Abcam GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Abcam Recent Developments/Updates
Table 82. Abcam Competitive Strengths & Weaknesses
Table 83. Corning Basic Information, Area Served and Competitors
Table 84. Corning Major Business
Table 85. Corning GPCR-targeting Drug Product and Services
Table 86. Corning GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Corning Recent Developments/Updates
Table 88. Corning Competitive Strengths & Weaknesses
Table 89. Discoverx Basic Information, Area Served and Competitors
Table 90. Discoverx Major Business
Table 91. Discoverx GPCR-targeting Drug Product and Services
Table 92. Discoverx GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Discoverx Recent Developments/Updates
Table 94. Cisbio Basic Information, Area Served and Competitors
Table 95. Cisbio Major Business
Table 96. Cisbio GPCR-targeting Drug Product and Services
Table 97. Cisbio GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of GPCR-targeting Drug Upstream (Raw Materials)
Table 99. GPCR-targeting Drug Typical Customers
Table 1. World GPCR-targeting Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World GPCR-targeting Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World GPCR-targeting Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World GPCR-targeting Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World GPCR-targeting Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World GPCR-targeting Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World GPCR-targeting Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World GPCR-targeting Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World GPCR-targeting Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key GPCR-targeting Drug Players in 2022
Table 12. World GPCR-targeting Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global GPCR-targeting Drug Company Evaluation Quadrant
Table 14. Head Office of Key GPCR-targeting Drug Player
Table 15. GPCR-targeting Drug Market: Company Product Type Footprint
Table 16. GPCR-targeting Drug Market: Company Product Application Footprint
Table 17. GPCR-targeting Drug Mergers & Acquisitions Activity
Table 18. United States VS China GPCR-targeting Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China GPCR-targeting Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based GPCR-targeting Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies GPCR-targeting Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies GPCR-targeting Drug Revenue Market Share (2018-2023)
Table 23. China Based GPCR-targeting Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies GPCR-targeting Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies GPCR-targeting Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based GPCR-targeting Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies GPCR-targeting Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies GPCR-targeting Drug Revenue Market Share (2018-2023)
Table 29. World GPCR-targeting Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World GPCR-targeting Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World GPCR-targeting Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World GPCR-targeting Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World GPCR-targeting Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World GPCR-targeting Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. PerkinElmer Basic Information, Area Served and Competitors
Table 36. PerkinElmer Major Business
Table 37. PerkinElmer GPCR-targeting Drug Product and Services
Table 38. PerkinElmer GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. PerkinElmer Recent Developments/Updates
Table 40. PerkinElmer Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific GPCR-targeting Drug Product and Services
Table 44. Thermo Fisher Scientific GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Merck Basic Information, Area Served and Competitors
Table 48. Merck Major Business
Table 49. Merck GPCR-targeting Drug Product and Services
Table 50. Merck GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Merck Recent Developments/Updates
Table 52. Merck Competitive Strengths & Weaknesses
Table 53. BD Biosciences Basic Information, Area Served and Competitors
Table 54. BD Biosciences Major Business
Table 55. BD Biosciences GPCR-targeting Drug Product and Services
Table 56. BD Biosciences GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. BD Biosciences Recent Developments/Updates
Table 58. BD Biosciences Competitive Strengths & Weaknesses
Table 59. Molecular Devices Basic Information, Area Served and Competitors
Table 60. Molecular Devices Major Business
Table 61. Molecular Devices GPCR-targeting Drug Product and Services
Table 62. Molecular Devices GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Molecular Devices Recent Developments/Updates
Table 64. Molecular Devices Competitive Strengths & Weaknesses
Table 65. Promega Basic Information, Area Served and Competitors
Table 66. Promega Major Business
Table 67. Promega GPCR-targeting Drug Product and Services
Table 68. Promega GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Promega Recent Developments/Updates
Table 70. Promega Competitive Strengths & Weaknesses
Table 71. Qiagen Basic Information, Area Served and Competitors
Table 72. Qiagen Major Business
Table 73. Qiagen GPCR-targeting Drug Product and Services
Table 74. Qiagen GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Qiagen Recent Developments/Updates
Table 76. Qiagen Competitive Strengths & Weaknesses
Table 77. Abcam Basic Information, Area Served and Competitors
Table 78. Abcam Major Business
Table 79. Abcam GPCR-targeting Drug Product and Services
Table 80. Abcam GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Abcam Recent Developments/Updates
Table 82. Abcam Competitive Strengths & Weaknesses
Table 83. Corning Basic Information, Area Served and Competitors
Table 84. Corning Major Business
Table 85. Corning GPCR-targeting Drug Product and Services
Table 86. Corning GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Corning Recent Developments/Updates
Table 88. Corning Competitive Strengths & Weaknesses
Table 89. Discoverx Basic Information, Area Served and Competitors
Table 90. Discoverx Major Business
Table 91. Discoverx GPCR-targeting Drug Product and Services
Table 92. Discoverx GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Discoverx Recent Developments/Updates
Table 94. Cisbio Basic Information, Area Served and Competitors
Table 95. Cisbio Major Business
Table 96. Cisbio GPCR-targeting Drug Product and Services
Table 97. Cisbio GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of GPCR-targeting Drug Upstream (Raw Materials)
Table 99. GPCR-targeting Drug Typical Customers
LIST OF FIGURES
Figure 1. GPCR-targeting Drug Picture
Figure 2. World GPCR-targeting Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GPCR-targeting Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World GPCR-targeting Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World GPCR-targeting Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 13. GPCR-targeting Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World GPCR-targeting Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of GPCR-targeting Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for GPCR-targeting Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for GPCR-targeting Drug Markets in 2022
Figure 27. United States VS China: GPCR-targeting Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GPCR-targeting Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World GPCR-targeting Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World GPCR-targeting Drug Market Size Market Share by Type in 2022
Figure 31. Reagent Test Kit
Figure 32. Substrate
Figure 33. World GPCR-targeting Drug Market Size Market Share by Type (2018-2029)
Figure 34. World GPCR-targeting Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World GPCR-targeting Drug Market Size Market Share by Application in 2022
Figure 36. Oncology
Figure 37. Cardiovascular
Figure 38. Central Nervous
Figure 39. Other
Figure 40. GPCR-targeting Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. GPCR-targeting Drug Picture
Figure 2. World GPCR-targeting Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GPCR-targeting Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World GPCR-targeting Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World GPCR-targeting Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company GPCR-targeting Drug Revenue (2018-2029) & (USD Million)
Figure 13. GPCR-targeting Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World GPCR-targeting Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India GPCR-targeting Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of GPCR-targeting Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for GPCR-targeting Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for GPCR-targeting Drug Markets in 2022
Figure 27. United States VS China: GPCR-targeting Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GPCR-targeting Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World GPCR-targeting Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World GPCR-targeting Drug Market Size Market Share by Type in 2022
Figure 31. Reagent Test Kit
Figure 32. Substrate
Figure 33. World GPCR-targeting Drug Market Size Market Share by Type (2018-2029)
Figure 34. World GPCR-targeting Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World GPCR-targeting Drug Market Size Market Share by Application in 2022
Figure 36. Oncology
Figure 37. Cardiovascular
Figure 38. Central Nervous
Figure 39. Other
Figure 40. GPCR-targeting Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
